Clinical Trial Update: Targeting Neuroinflammation as a Contributing Pathology in Alzheimer's Disease Dementia and Related Dementias [Phase 2]

View source ↗

Summary

Phase 2 trial investigating neuroinflammation as a contributing pathology in Alzheimer's disease dementia and related dementias; enrollment is by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Dementia with Lewy Bodies

Snippet

Sponsor: Val Lowe | Conditions: Alzheimer Disease, Lewy Body's Dementia | Phase 2 | Status: ENROLLING_BY_INVITATION